The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

July 31, 2007

Conditions

Hyperphosphatemia

Interventions

DRUG

Niacinamide

Niacinamide 250 mg twice daily titrated up to 750 mg twice daily

DRUG

Placebo

Trial Locations (1)

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT00508885 - The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients | Biotech Hunter | Biotech Hunter